These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8427041)
21. Immunization in the developing world: strategic challenges. Nokes DJ; Cutts FT Trans R Soc Trop Med Hyg; 1993; 87(4):353-4, 398. PubMed ID: 8249056 [No Abstract] [Full Text] [Related]
23. Oral poliomyelitis vaccine: time to change? Swennen B; Levy J Vaccine; 2001 Mar; 19(17-19):2262-7. PubMed ID: 11257345 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco]. Caidi H; Bennis IF; Mouan N; El Aouad R East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637 [TBL] [Abstract][Full Text] [Related]
25. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization. Khan MM; Sharma S; Tripathi B; Alvarez FP Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194 [TBL] [Abstract][Full Text] [Related]
26. Polio eradication, cessation of vaccination and re-emergence of disease. Minor PD Nat Rev Microbiol; 2004 Jun; 2(6):473-82. PubMed ID: 15152203 [No Abstract] [Full Text] [Related]
28. Polio and measles: reasons of missed vaccination in Italy, 2015-2017. Gianfredi V; D'Ancona F; Maraglino F; Cenci C; Iannazzo S Ann Ig; 2019; 31(3):191-201. PubMed ID: 31069364 [TBL] [Abstract][Full Text] [Related]
29. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES. MACLEOD DR Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761 [TBL] [Abstract][Full Text] [Related]
31. [New assumptions in the concept of vaccine prophylaxis of infantile infections]. Semenov BF Vestn Ross Akad Med Nauk; 2003; (1):20-4. PubMed ID: 12608080 [TBL] [Abstract][Full Text] [Related]
32. [Practice of protective vaccination and vaccination legislation in the DDR]. Morenz J; Fostitsch V Z Arztl Fortbild (Jena); 1966 Mar; 60(5):279-82. PubMed ID: 4966984 [No Abstract] [Full Text] [Related]
33. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Laws HJ; Calaminus G; Göbel U Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299 [No Abstract] [Full Text] [Related]
34. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Fioredda F; Giacchino M; Castagnola E Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298 [No Abstract] [Full Text] [Related]
35. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637 [TBL] [Abstract][Full Text] [Related]
36. Current status of vaccine-preventable diseases. Witte JJ Postgrad Med; 1974 Oct; 56(4):55-9. PubMed ID: 4412686 [No Abstract] [Full Text] [Related]
37. Enough With Polio: It's Measles' Turn Now in Pakistan. Rehman IU; Khan TM Disaster Med Public Health Prep; 2016 Aug; 10(4):539-40. PubMed ID: 27263952 [No Abstract] [Full Text] [Related]
38. Polio vaccines: WHO position paper, January 2014. Wkly Epidemiol Rec; 2014 Feb; 89(9):73-92. PubMed ID: 24707513 [No Abstract] [Full Text] [Related]
39. Success and failure in human virus disease. IV. Immunization. Stuart-Harris C Br Med J; 1971 Feb; 1(5746):446-8. PubMed ID: 4926368 [No Abstract] [Full Text] [Related]
40. [Perspectives in the eradication of the immuno-preventable diseases]. Navarro Alonso JA; Arístegui Fernández Jd Med Clin (Barc); 2002 Nov; 119(15):574-8. PubMed ID: 12421510 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]